Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 8, 2007, Pages 820-826

  Ho, Viet H ^a   Ross, Merrick I ^a   Prieto, Victor G ^a,b   Khaleeq, Aisha ^a   Kim, Stella ^a   Esmaeli, Bita ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PEROPERATIVE CARE; REVIEW; SEBACEOUS CARCINOMA; SENTINEL LYMPH NODE BIOPSY; TERTIARY HEALTH CARE; TISSUE SECTION;

ADENOCARCINOMA, SEBACEOUS; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; EYE NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SEBACEOUS GLAND NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 34548076066     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.8.820     Document Type: Review

References (34)

1. Reintgen D, Cruse CW, Wells KE, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220(6):759-767.
2. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976-983.
3. Medina-Franco H, Beenken SW, Heslin MJ, et al. Sentinel node biopsy for cutaneous melanoma in the head and neck. Ann Surg Oncol. 2001;8(9):716-719.
4. Bostick P, Essner R, Sarantou T, et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg. 1997;174(5):536-539.
5. McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86(4):212-223.
6. Wells KE, Rapaport DP, Wayne CC, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997;100(3):591-594.
7. Wagner JD, Park HM, Coleman JJ, et al. Cervical lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg. 2000;126(3):313-321.
8. Schmalbach CE, Lowe L, Teknos TN, et al. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131(7):610-614.
9. Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088-2098.
10. Faustina M, Diba R, Ahmadi A, Esmaeli B. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology. 2004;111(10):1930-1932.
11. Amato M, Esmaeli B, Ahmadi A, et al. Feasibility of preoperative lymphoscintigraphy for identification of sentinel lymph nodes in patients with conjunctival and periocular skin malignancies. Ophthal Plast Reconstr Surg. 2003;19(2):102-106.
12. Nijhawan N, Ross MR, Diba R, Ahmadi MA, Esmaeli B. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg. 2004;20(4):291-295.
13. Esmaeli B, Reifler D, Preito VG, et al. Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol. 2003;121(12):1779-1783.
14. Esmaeli B, Naderi A, Hidaji L, Blumenschein G, Prieto VG. Merkel cell carcinoma of the eyelid with a positive sentinel node. Arch Ophthalmol. 2002;120(5):646-648.
15. Esmaeli B. Advances in the management of malignant tumors of the eyelid and conjunctiva: the role of sentinel lymph node biopsy. Int Ophthalmol Clin. 2002;42(2):151-162.
16. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol. 2002;6(4):257-264.
17. Wilson MW, Fleming JC, Fleming RM, et al. Sentinel node biopsy for orbital and ocular adnexal tumors. Ophthal Plast Reconstr Surg. 2001;17(5):338-345.
18. Esmaeli B, De Martelaere S, Ozkan Y, Prager T, Prieto V, Diwan H. Surgical specimen handling for conjunctival melanoma: implications for tumor thickness determination and sentinel lymph node biopsy. Ophthal Plast Reconstr Surg. 2006;22(3):238-239.
19. Schmalbach CE, Nussenbaum B, Rees RS, Schwartz J, Johnson TM, Bradford CR. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2003;129(1):61-65.
20. Eicher SA, Clayman GL, Myers JN, Gillenwater AM. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2002;128(3):241-246.
21. Vuylsteke RJ, van Leeuwen PAM, Muller MGS, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol. 2003;21(6):1057-1065.
22. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanoma. Ann Surg Oncol. 2003;10(1):21-26.
23. O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg. 1995;170(5):461-466.
24. Jansen L, Koops HS, Nieweg OE, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck. 2000;22(1):27-33.
25. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999;86(4):617-627.
26. Esmaeli B, Eicher S, Delpassand E, et al. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg. 2001;17(6):436-442.
27. Tuomaala S, Kivela T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology. 2004;111(4):816-821.
28. Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the eyelids, personal experience with 60 cases. Ophthalmology. 2004;111(12):2151-2157.
29. Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50(2):103-122.
30. Rousseau DL, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol. 2003;10(5):569-574.
31. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16(6):2253-2260.
32. Esmaeli B, Wang X, Youssef A, Gershenwald JE. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology. 2001;108(11):2101-2105.
33. Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg. 2000;16(4):250-257.
34. Chao AN, Shields CL, Krema H, Shields JA. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001;108(10):1877-1883.